Fachliteratur Gastroenterologie: Portale Hypertonie

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Portale Hypertonie

08. November 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 546


	Artikel 1 - 20 / 10913

	Multiparametric ultrasound for the prediction of the short-term outcome after esophageal varices band ligation. World J Gastroenterol Ainora ME, Borriello R, Pecere S, Paratore M, Galasso L, Calvez V, Esposto G, Mignini I, Barbaro F, Del Vecchio LE, Ponziani FR, Annicchiarico BE, Garcovich M, Riccardi L, Pompili M, Spada C, Gasbarrini A, Zocco MA. PMID: 41180996 [PubMed - indexed for MEDLINE]
	Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD. Liver Int Liu M, Zhang X, Cheng X, He Q, Zhou T, Wang H, Li B, Luo W, Li J, Li H, Lin Z, Song J, Wang W, Huang J, Ji Y, Zhou D, Xie W, Yang Q, Tu M, Luo X, Zhang X, Yan H, Chen J. PMID: 41178521 [PubMed - indexed for MEDLINE]
	Adding 100â€‰Hz Spleen Stiffness Measurement to the Baveno VII Model Improves Decompensation Risk Prediction in cACLD. Liver Int Vanderschueren E, Laleman W. PMID: 41174953 [PubMed - indexed for MEDLINE]
	Portal hypertension in biliary atresia: a Japanese biliary atresia registry study. Pediatr Surg Int Okubo R, Nio M, Sasaki H, Fukuzawa T, Kudo H, Ando R, Sakurai T, Hashimoto M, Tada K, Wada M, Japanese Biliary Atresia Society. PMID: 41171449 [PubMed - indexed for MEDLINE]
	Splenic stiffness does not predict esophageal varices in children with portal hypertension. J Pediatr Gastroenterol Nutr Jezequel M, El Fayoumi M, Aumar M, Tran L, Saingier C, Behal H, Antoine M, Gottrand F. PMID: 41144851 [PubMed - as supplied by publisher]
	Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis. J Hepatol Bañares J, Pons M, Reiberger T, Mandorfer M, Jachs M, Semmler G, Colecchia A, Colecchia L, Dajti E, Bureau C, Larrue H, Grgurevi, Kujund, Fortea JI, Puente A, Berzigotti A, Tsochatzis E, Bosch J, Abraldes JG, Genesca J, a study by the Baveno Cooperation: an EASL consortium. PMID: 41138818 [PubMed - as supplied by publisher]
	Comparative study of classic Rex shunt and modified Rex shunt in treating portal cavernoma in children. Sci Rep Zhang JS, Li L. PMID: 41131027 [PubMed - indexed for MEDLINE]
	Serum bile acid levels predict the development of portal hypertension and high-risk esophageal varices following successful Kasai in biliary atresia. Hepatology Grimaud E, Gardin A, Ackermann O, Habes D, Hermeziu B, Thébaut A, Le Cam S, Franchi-Abella S, Lambert V, Fouquet V, Pio L, Guérin F, Duché M, Jacquemin E, Almes M, Gonzales E. PMID: 41129338 [PubMed - as supplied by publisher]
	Clip-assisted endoscopic cyanoacrylate injection vs endoscopic ultrasound-guided coil and cyanoacrylate injection for gastric varices: A propensity score-matched study. World J Gastroenterol Xiong YY, Li DW, Zhou TY, Ma H, Gao JG, Shen Z, Xu CF, Yu CH. PMID: 41112012 [PubMed - indexed for MEDLINE]
	Portal cavernoma cholangiopathy: A systematic review of current understanding, clinical significance, and management. Hepatol Commun Pinto E, Elkrief L, Hernández-Gea V, Busatto A, Ferdinande K, Zanetto A, Shukla A, Senzolo M. PMID: 41085547 [PubMed - indexed for MEDLINE]
	The pathophysiological role of portal hypertension in metabolic dysfunction-associated steatotic liver disease. Hepatol Commun Møller S, Sjöstedt SMS, Hobolth L, Mortensen C, Kimer N. PMID: 41085539 [PubMed - indexed for MEDLINE]
	Comparison of artificial neural network-predicted PPG and HVPG with measured PPG in decompensated cirrhosis patients. Sci Rep Wang Z, Liu Z, Lv M, Wang Y, Yu Y, Li T, Hu J. PMID: 41083502 [PubMed - indexed for MEDLINE]
	Pediatric Portal Hypertension Interventions: Ectopic Varices, Portal Vein Recanalization, Portosystemic Shunt Creation, and Maintenance of Surgical Shunts. Semin Intervent Radiol AlRamahi R, Marra P, Chewning RH, Shin DS, Chick JFB, Monroe EJ. PMID: 41080112 [PubMed]
	[Prevention of decompensation in advanced chronic liver disease]. Dtsch Med Wochenschr Reincke M, Sturm L, Thimme R, Bettinger D. PMID: 41072426 [PubMed - indexed for MEDLINE]
	Critical appraisal of 'comparison of laparoscopic versus open oesophagogastric devascularisation with splenectomy in portal hypertension: A meta-analysis'. J Minim Access Surg Karthik N, Lodha M, Swathi M. PMID: 41059841 [PubMed - as supplied by publisher]
	Circulating extracellular vesicles predict outcome in patient undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. Sci Rep Loosen SH, Hansen FJ, Schatilow D, Wirtz T, Reuken PA, Bode J, Kunstein A, Vucur M, Reißing J, Flügen G, Castoldi M, Stallmach A, Luedde T, Bruns T, Roderburg C. PMID: 41057479 [PubMed - indexed for MEDLINE]
	Partial Splenic embolization combined with endoscopic variceal ligation in variceal rebleeding prevention among liver cirrhosis patients complicated with hypersplenism, thrombocytopenia, and esophagogastric variceal hemorrhage: a prospective observational study. BMC Gastroenterol Yue B, Yang D, Lu Z, Zhao S, Tang Z. PMID: 41053614 [PubMed - indexed for MEDLINE]
	Use of Noninvasive Tests to Assess Clinically Significant Portal Hypertension and Response to Beta-Blockers. Gastro Hep Adv Rudra OS, Jindal A, Sarin SK. PMID: 41049398 [PubMed]
	Early implantation of a transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis and ascitesÂ (eTIPS): a multicentre, randomised controlled trial. Trials Bettinger D, Janoschke M, Jenkner C, Kaufmann M, van Gessel J, Otter HH, Schultheiss M, Thimme R, on behalf of the eTIPS study group. PMID: 41039580 [PubMed - indexed for MEDLINE]
	Portal hypertension contributes to ascites formation via the Piezo1-nuclear factor kappa-B-aquaporin1 pathway in liver cirrhosis. Exp Mol Med Wei N, Du L, Xiao Z, Zhang L, Zhou Y, Gao H, Liu M, Wang C, Hou X, Li Y, Song Y. PMID: 41034523 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 10913

Seite 1 von 546



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung